Rezultati pretraživanja
  1. 14. svi 2019.

    Attended ContraFect’s symposia on 180-day follow-up data on Phase 2 results. Patients treated with lysin + SOC drugs left the hospital sooner and did not return due to relapse more often than SOC drugs alone - Significant!

  2. 1. velj 2010.

    did you ever wonder how cartels are created. here you go - FBI video taped a meeting http://bit.ly/dpcCZY via @S_V_L_SS_

  3. 18. ruj 2019.

    Happy that this book chapter on is finally out. Learn more about this exciting and emerging class of antibiotics with a novel mode-of-action!

    Prikaži ovu nit
  4. 1. velj 2019.
  5. 18. ruj 2019.

    It was more than a year on the publishers table, so we couldn't include the many exciting advances in research reported this year, though a recommended read for all who are interested to enter and to follow-up this field...

    Prikaži ovu nit
  6. 29. sij

    Phage lysins have been moving rapidly towards acceptance as antibiotic alternatives. Thus, we are postponing “The Third International Lysin Meeting” from 10/2020 to 10/26-28/2021 at Rockefeller U in New York. Block out these dates on your Calendar.

  7. 3. kol 2018.

    I de-excited the trinitroglycerin incoherently. You uncanonized the corpora striata impetuously.

  8. 12. ruj 2018.

    Less than 2 months until .com in NYC. Abstract deadline October 5th. Be part of the event - get your abstract in.

  9. 16. ruj 2018.

    phage derived enzymes could be here to stay as substitute of antibiotics

    Prikaži ovu nit
  10. 27. pro 2015.

    I de-excited the heterophoria munificently. You diversified the memorabilia instrumentally.

  11. 5. pro 2015.

    Tuberculinise linear independence idolatrously.

  12. Today's to goes to Eunsu Ha & Bokyun Son for their paper showing the potential for a to detect & kill perfringens

  13. 15. ožu 2019.

    Hand-To-Mouth shelter seventy kitchen police exuberantly.

  14. 4. tra 2019.

    Too many prescribed in Belgium because doctors do not want to take a risk. Time for rapid and precise Risks are avoided and no collateral damage

  15. 9. tra 2018.
  16. 6. lip 2019.

    ContraFect awarded $7.2M USAMRDC grant to advance CF-296: new is engineered variant, Phase2 study showed improved clinical outcomes for MRSA -- 43% higher with

  17. 26. ožu 2019.

    Had a great meet n discussion. Thanks ⁦⁩, nice to interact with your team.

  18. 3. velj

    Unsere Spezial-Formula sorgt für eine Extra-Zufuhr der -Moleküle und , zwei wichtigen Bausteinen im biologischen unseres .

  19. 3. velj

    Our latest article in about "Mycobacteriophage-derived (mycolyl arabinogalactan hydrolase)". and studies of 30 LysB and Act Ass of LysBs. Active site conformations might affect LysB activity.

    Prikaži ovu nit

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.